A Study to Assess the Safety and Effects of the Investigational Drug BW-40202 in Healthy Volunteers

Clinical trial NCT06917482 · RECRUITING

Trial details

NCT number: NCT06917482
Sponsor: Shanghai Argo Biopharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers Only

Start date: 2025-06-30
Primary completion: 2026-07-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.